Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
According to Varun Goel of Motilal Oswal Asset Management, one may stay away from real estate sector.
SP Tulsian of sptulsian.com is of the view that one may see 4-5 percent upside in Housing Development and Infrastructure.
Prakash Diwan of prakashdiwan.in is of the view that one may look at Housing Development and Infrastructure.
Here are top 10 stocks picked up by CNBC-TV18's analysts in trade today - IDBI Bank, Indiabulls Real Estate, Marksans Pharma, Marico, NBCC, Sun Pharma, Interglobe Aviation, Cadila, HDIL, Eros International, Godrej Properties and Raymond.
Mayuresh Joshi of Angel Broking is of the view that one may prefer Sun Pharmaceutical Industries with long term view.
Aditya Agarwal, Senior Derivative Analyst at Way2Wealth Securities recommends buying Ceat, Bharat Forge and HDIL and advises shorting ITC.
Rahul Shah, Associate VP, Equity Advisory Group at Motilal Oswal advises buying Housing Development and Infrastructure strike put.
Vishal Malkan of www.malkansview.com advises buying Federal Bank with a stoploss at Rs 53 and target of Rs 60.
Vishal Malkan of www.malkansview.com advises buying TVS Motor with a target of Rs 295.
CA Rudramurthy of Vachana Investments is of the view that one may sell Jubilant Foodworks with a target of Rs 1333.
Vishal Malkan of malkansview.com advises selling CESC with a target of Rs 540.
Rakesh Bansal of RK Global recommends selling Ceat, HDIL, IRB Infra and Aurobindo Pharma.
Vishal Malkan of malkansview.com is of the view that one may buy Ashok Leyland with a target of Rs 97.
Shubham Agarwal of Motilal Oswal Securities recommends buying BPCL, Bosch and HPCL and advises selling Siemens and HDIL.
Shubham Agarwal of Motilal Oswal Securities recommends selling HDIL for a target of Rs 58.
Manav Chopra of Monarch Networth Capital suggests buying Apollo Hospitals Enterprises with a target of Rs 1420.
Vishal Malkan of malkansview.com advises buying Jubilant Life Sciences with a target of Rs 470.
Manav Chopra of Monarch Networth Capital is of the view that HDIL may hit Rs 67.
Krish Subramanyam of Altamount Capital is of the view that one may buy Inox Leisure with a target of Rs 240.
Gaurav Ratnaparkhi of Sharekhan is of the view that one may sell HDIL with a target of Rs 72.
VK Sharma of HDFC Securities recommends buying Housing Development and Infrastructure 75 Call.
CA Rudramurthy BV of Vachana Investments advises buying Ramco Industries with a target of Rs 119.
Vishal Malkan of malkansview.com is of the view that one may buy Dish TV India with a target of Rs 112.
Hemen Kapadia of KRChoksey Securities is of the view that one may sell Housing Development and Infrastructure on bounce.
Jay Thakkar of Sharekhan advises buying MphasiS with a target of Rs 444.